How well are patients with atherosclerotic disease treated? Secondary prevention in primary care

Scandinavian Journal of Primary Health Care

Volumn 18, Issue 4, 2000, Pages 232-236

  Svilaas, A ^a   Thoresen, M ^a   Kristoffersen, J E ^a   Hjartaaker, J ^a   Westheim, A ^a  

^a Nymoen Iegekontor   (Norway)

Author keywords

Atherosclerosis; General practice; Lipid lowering drugs; Multipractice survey; Risk factors; Secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STATIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CIGARETTE SMOKING; DRUG EFFECT; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PATIENT CARE; PRESCRIPTION; PRIMARY MEDICAL CARE; RISK FACTOR; SECONDARY PREVENTION; SMOKING CESSATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; AGED, 80 AND OVER; ANTILIPEMIC AGENTS; ARTERIOSCLEROSIS; CHOLESTEROL; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; NORWAY; PHYSICIAN'S PRACTICE PATTERNS; RISK FACTORS;

EID: 0034519801     PISSN: 02813432     EISSN: None     Source Type: Journal    
DOI: 10.1080/028134300448805     Document Type: Article

References (23)

1. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension
2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
4. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
5. Effects for statins on risk of coronary disease
6. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
7. Aspirin
8. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events)
9. A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results
10. Risikofaktorer og intervensjon ved hjerte- og karsykdommer i allmennpraksis. (Risk factors and intervention in cardiovascular diseases in general practice.)
11. Hvor godt behandles pasienter med aterosklerotisk sykdom i allmennpraksis? (How well are patients with atherosclerotic disease treated in general practice?)
12. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
13. National cholesterol education program: Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol levels in adults
14. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention
15. Lipids and cardiovascular disease
16. Aspirin use is low among United States outpatients with coronary artery disease
17. Guidelines Sub-Committee of the World Health Organization - International Society of Hypertension (WHO-ISH). 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension
18. Beta-blockers continue to surprise us
19. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction
20. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
21. West of Scotland Coronary Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials
22. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels